27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Although US stocks closed mixed on Friday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
IAC
- The Trade: IAC Inc. (NASDAQ:IAC) Director Michael D Eisner acquired a total of 106,241 shares an average price of $47.13. To acquire these shares, it cost around $5.01 million.
- What’s Happening: The company recently posted downbeat quarterly results.
- What IAC Does: IAC/InterActiveCorp, headquartered in New York operates as a media and internet company worldwide.
GoHealth
- The Trade: GoHealth, Inc. (NASDAQ:GOCO) 10% owner CB Blizzard Holdings C, L.P. acquired a total of 83,215 shares at an average price of $8.58. To acquire these shares, it cost around $713.66 thousand.
- What’s Happening: The company recently posted a narrower-than-expected quarterly loss.
- What GoHealth Does: GoHealth, founded in 2001, operates as a health insurance marketplace and Medicare focused digital health company in the United States.
Don’t forget to check out our premarket coverage here .
Also check this: Nasdaq Settles Lower, Market Volatility Rises Sharply
MacroGenics
- The Trade: MacroGenics, Inc. (NASDAQ:MGNX) 10% owner BB Biotech AG bought a total of 300,000 shares at an average price of $5.96. To acquire these shares, it cost around $1.79 million.
- What’s Happening: Citigroup recently downgraded Macrogenics from Buy to Neutral and lowered the price target from $16 to $7.
- What MacroGenics Does: MacroGenics, headquartered in Rockville, Maryland, is a biopharmaceutical company.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.